Sorafenib is a multikinase inhibitor used for the treatment of uHCC 10 Two Phase III studies (SHARP and Asia-Pacific) demonstrated significant improvements in overall survival in Hepatocellular Carcinoma
Continue reading“These results suggested that antineoplaston A10 may inhibit the growth of human hepatoma cells through the induction of apoptosis” Conventional oncology may have little to offer the liver
Continue reading